[go: up one dir, main page]

GB0821093D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB0821093D0
GB0821093D0 GBGB0821093.2A GB0821093A GB0821093D0 GB 0821093 D0 GB0821093 D0 GB 0821093D0 GB 0821093 A GB0821093 A GB 0821093A GB 0821093 D0 GB0821093 D0 GB 0821093D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0821093.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Modern Biosciences Ltd
Original Assignee
Modern Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modern Biosciences Ltd filed Critical Modern Biosciences Ltd
Priority to GBGB0821093.2A priority Critical patent/GB0821093D0/en
Publication of GB0821093D0 publication Critical patent/GB0821093D0/en
Priority to PCT/GB2009/002700 priority patent/WO2010058166A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0821093.2A 2008-11-18 2008-11-18 Treatment Ceased GB0821093D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0821093.2A GB0821093D0 (en) 2008-11-18 2008-11-18 Treatment
PCT/GB2009/002700 WO2010058166A1 (fr) 2008-11-18 2009-11-18 Utilisation du rimcazole pour le traitement de troubles oculaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0821093.2A GB0821093D0 (en) 2008-11-18 2008-11-18 Treatment

Publications (1)

Publication Number Publication Date
GB0821093D0 true GB0821093D0 (en) 2008-12-24

Family

ID=40194839

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0821093.2A Ceased GB0821093D0 (en) 2008-11-18 2008-11-18 Treatment

Country Status (2)

Country Link
GB (1) GB0821093D0 (fr)
WO (1) WO2010058166A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007842D0 (en) * 2000-03-31 2000-05-17 Spruce Barbara Sigma receptor ligands and their medical uses
GB0419145D0 (en) * 2004-08-27 2004-09-29 Univ Dundee Treatment of posterior capsule opacification
GB0724340D0 (en) * 2007-12-13 2008-01-30 Univ Dundee Novel Therapeutic Agents

Also Published As

Publication number Publication date
WO2010058166A1 (fr) 2010-05-27

Similar Documents

Publication Publication Date Title
GB0823213D0 (en) Treatment
GB0802116D0 (en) Treatment
EP2322076A4 (fr) Endoscope de traitement
IL206654A0 (en) Combination therapy
GB0822011D0 (en) Treatment
IL212348A0 (en) Treatment method
GB0711342D0 (en) Well treatment
GB0800145D0 (en) Skincare treatment
GB0807850D0 (en) Treatment device
GB0811992D0 (en) Treatment
GB0900599D0 (en) Treatment
GB201013898D0 (en) Well treatment
GB0716784D0 (en) Well treatment
GB0913968D0 (en) Treatment
GB0802201D0 (en) Treatment system
GB0820972D0 (en) Treatment
GB201001521D0 (en) Treatment
GB0822077D0 (en) Novel treatments
GB0803948D0 (en) Combination therapy
GB0805912D0 (en) Treatment
GB0823273D0 (en) Treatment system
GB0809046D0 (en) Cancer treatment
GB0820534D0 (en) Treatment
GB0820379D0 (en) Treatment
GB0816892D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)